Literature DB >> 14679450

Emergence of echovirus type 13 as a prominent enterovirus.

James A Mullins1, Nino Khetsuriani, William A Nix, M Steven Oberste, Ashley LaMonte, David R Kilpatrick, James Dunn, Janine Langer, Peter McMinn, Q Sue Huang, Keith Grimwood, Cinnia Huang, Mark A Pallansch.   

Abstract

In 2001, increased activity of the rarely detected enterovirus echovirus type 13 (E13) was observed in the United States. This article describes the epidemiologic, clinical, and genetic characteristics of E13 activity in the United States in 2001, compared with E13 activity abroad in 2000-2002. In the United States, E13 accounted for 376 (24%) of the 1584 enterovirus isolates reported in 2001 (29% of the reported isolates had a known serotype), compared with 74 isolates reported during 1970-2000. Five states reported aseptic meningitis outbreaks associated with E13, for a total of 521 cases. All characterized E13 isolates from the United States, Europe, Asia, and Oceania recovered in 2000-2002 were at least 95% identical to each other in VP1 capsid gene sequence, but they were genetically distinct from E13 isolates recovered before 2000. Continued surveillance of enteroviruses is important to alert physicians and public health officials to changes in disease trends and to improve efficiencies of clinical intervention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14679450     DOI: 10.1086/380462

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

1.  Widespread circulation of echovirus type 13 demonstrated by increased seroprevalence in Toyama, Japan, between 2000 and 2003.

Authors:  Masae Iwai; Hiromu Yoshida; Mayumi Obara; Eiji Horimoto; Kazuya Nakamura; Takenori Takizawa; Takeshi Kurata; Mineyuki Mizuguchi; Tohru Daikoku; Kimiyasu Shiraki
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

2.  Isolation and identification of enteroviruses from sewage and sewage-contaminated water in Lagos, Nigeria.

Authors:  Johnson Adekunle Adeniji; Temitope Oluwasegun Cephas Faleye
Journal:  Food Environ Virol       Date:  2014-02-25       Impact factor: 2.778

Review 3.  Enteroviruses as agents of emerging infectious diseases.

Authors:  G Palacios; M S Oberste
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

4.  Molecular epidemiology of echoviruses 11 and 13, based on an environmental surveillance conducted in Toyama Prefecture, 2002-2003.

Authors:  Masae Iwai; Hiromu Yoshida; Kumiko Matsuura; Tsuguto Fujimoto; Hiroyuki Shimizu; Takenori Takizawa; Yoshiyuki Nagai
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

5.  Surveillance of enteroviruses in France, 2000-2004.

Authors:  D Antona; N Lévêque; J J Chomel; S Dubrou; D Lévy-Bruhl; B Lina
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-06       Impact factor: 5.103

6.  A retrospective overview of enterovirus infection diagnosis and molecular epidemiology in the public hospitals of Marseille, France (1985-2005).

Authors:  Charlene Y Q Tan; Laetitia Ninove; Jean Gaudart; Antoine Nougairede; Christine Zandotti; Laurence Thirion-Perrier; Remi N Charrel; Xavier de Lamballerie
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

7.  Echovirus 13 aseptic meningitis, Brazil.

Authors:  Claudete I Kmetzsch; Estela M R Balkie; Anita Monteiro; Eliane V Costa; Gina P L dos Santos; Edson E da Silva
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

8.  Antigenic diversity of enteroviruses associated with nonpolio acute flaccid paralysis, India, 2007-2009.

Authors:  C Durga Rao; Prasanna Yergolkar; K Subbanna Shankarappa
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

9.  Genetic variants of echovirus 13, northern India, 2010.

Authors:  Harjeet Singh Maan; Rashmi Chowdhary; Akhalesh Kumar Shakya; Tapan N Dhole
Journal:  Emerg Infect Dis       Date:  2013-02       Impact factor: 6.883

10.  Epidemics of viral meningitis caused by echovirus 6 and 30 in Korea in 2008.

Authors:  Hye-Jin Kim; Byounghak Kang; Seoyeon Hwang; Jiyoung Hong; Kisang Kim; Doo-Sung Cheon
Journal:  Virol J       Date:  2012-02-15       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.